The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $708,305 in first-year total cost, median $233,402.
Most frequent study sections
- Drug Discovery for the Nervous System Study Section[DDNS]2
- Imaging Probes and Contrast Agents Study Section[IPCA]1
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, MERCED1
- UNIVERSITY OF MISSOURI-COLUMBIA1
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Development of 1,4-Benzodioxane Derivatives as F-18 PET Radiotracers for Alpha-2C Adrenergic Receptors and Their Preclinical Evaluations1R21AG083663-01A1 | KIL, KUN-EEK | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $233,402 | IPCA |
| 2022 | Discovery of Cell-based Chemical Probes Targeting Aberrant Angiogenesis in the Eye1R21EY032632-01A1 | HURYN, DONNA MKOES, DAVID RYANROY, PARTHAVANDEMARK, ANDREW PAUL | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $270,779 | DDNS |
| 2022 | BAF complex inhibitors in neuronal development and functions1R21MH128678-01A1 | DYKHUIZEN, EMILY CARLASAHA, RAMENDRA N | UNIVERSITY OF CALIFORNIA, MERCED, CA | $204,124 | DDNS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.